DekaBank Deutsche Girozentrale’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-13,000	Closed	-$105K	–	1499
2021 Q3	$105K	Hold	13,000	–	–	﹤0.01%	1297
2021 Q2	$104K	Hold	13,000	–	–	﹤0.01%	1324
2021 Q1	$129K	Hold	13,000	–	–	﹤0.01%	1259
2020 Q4	$155K	Buy	+13,000	New	+$163K	﹤0.01%	1215

Other funds holding FUSN

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

ASP

Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

PBPIA

Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

DekaBank Deutsche Girozentrale's FUSN Position: Q4 2021 in Review

DekaBank Deutsche Girozentrale sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q4 2021, closing a stake of 13,000 shares — an estimated $105K sold.

DekaBank Deutsche Girozentrale first reported a position in FUSN in Q4 2020 and held it in 4 quarters. The position peaked at $155K in Q4 2020. 32 funds tracked by Wall St. Rank hold FUSN as of Q4 2021.

DekaBank Deutsche Girozentrale reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q4 2021 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 13,000 Fusion Pharmaceuticals Inc. Common Shares shares in Q4 2021, an estimated $105K.
DekaBank Deutsche Girozentrale first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q4 2020 and held it in 4 quarters.
DekaBank Deutsche Girozentrale's Fusion Pharmaceuticals Inc. Common Shares position peaked at $155K in Q4 2020.
32 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q4 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2021, filed 2 Feb 2022.